Latest news
Physician Views Preview: Orzeyful arrives — Will Takeda's drug redefine narcolepsy treatment? - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 16:47:18 GMTThe First Narcolepsy Drug That Treats the Underlying Disease Is Approved but Not Yet Available to Patients - Medical DailyMedical Daily · Mon, 10 Aug 2026 10:10:04 GMTFDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1 - Managed Healthcare ExecutiveManaged Healthcare Executive · Fri, 07 Aug 2026 20:06:51 GMTFDA approves first-in-class drug to treat narcolepsy - Drug Discovery NewsDrug Discovery News · Fri, 07 Aug 2026 19:48:16 GMTFDA approves Takeda’s first-in-class narcolepsy drug - EMJEMJ · Fri, 07 Aug 2026 15:12:52 GMTFDA approves Orzeyful for narcolepsy type 1 in adults - American Academy of Sleep Medicine | AASMAmerican Academy of Sleep Medicine | AASM · Fri, 07 Aug 2026 14:23:12 GMTFierce Pharma Asia—Takeda’s historic narcolepsy nod; Daiichi’s accounting error; Astellas’ revenue beat - Fierce PharmaFierce Pharma · Fri, 07 Aug 2026 12:35:10 GMTFDA Approves First Narcolepsy Drug That Targets the Brain Signal Loss Behind the Disorder - Medical DailyMedical Daily · Fri, 07 Aug 2026 10:30:02 GMT